Christina J. Ansted

Christina J. Ansted, MPH, CCMEP, serves as an Advisory Board Member at Cila Therapeutics, offering strategic guidance in the commercialization of therapeutic products for chronic obstructive respiratory diseases. As the Founder and Chief Executive Officer of Rapid Commercialization Partners, Christina Ansted optimizes commercialization processes for clinical-stage biotechnology companies. Previous roles include Executive Director of Global Shared Medical Services at PTC Therapeutics, where Christina Ansted established a center of excellence for patient finding and diagnostics, and Senior Director of Global Marketing Gene Therapy at Agilis Biotherapeutics. With extensive experience in global marketing and medical affairs across multiple pharmaceutical companies, Christina Ansted has successfully led marketing initiatives for various therapeutic areas and contributed to the development of successful global launch strategies. Educationally, Christina Ansted holds a Master's in Public Health from New York Medical College and a Bachelor's in Biological Science from the University of Vermont.